Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David J Stott

Showing results (131-140 of 215) with videos related to

Pageof 22
Sort By:
BMJ (Clinical Research Ed.)|August 1, 2013
Association of visit-to-visit variability in blood pressure with cognitive function in old age: prospective cohort studyBehnam Sabayan, Liselotte W Wijsman, Jessica C Foster-Dingley, et al.
Plos Medicine|June 26, 2009
Are markers of inflammation more strongly associated with risk for fatal than for nonfatal vascular events?Naveed Sattar, Heather M Murray, Paul Welsh, et al.
Journal of Neurology|August 5, 2009
Pravastatin and cognitive function in the elderly. Results of the PROSPER studyStella Trompet, Peter van Vliet, Anton J M de Craen, et al.
The Journal of Clinical Endocrinology and Metabolism|November 9, 2019
Skeletal Effects of Levothyroxine for Subclinical Hypothyroidism in Older Adults: A TRUST Randomized Trial Nested StudyElena Gonzalez Rodriguez, Mirah Stuber, Cinzia Del Giovane, et al.
Current Controlled Trials in Cardiovascular Medicine|July 5, 2002
A Prospective Study of Pravastatin in the Elderly at Risk (PROSPER): Screening Experience and Baseline CharacteristicsIan Ford, Gerard Jan Blauw, Michael B Murphy, et al.
Plos One|June 6, 2012
Genome-wide study of gene variants associated with differential cardiovascular event reduction by pravastatin therapyDov Shiffman, Stella Trompet, Judy Z Louie, et al.
Lancet (London, England)|May 27, 2008
Can metabolic syndrome usefully predict cardiovascular disease and diabetes? Outcome data from two prospective studiesNaveed Sattar, Alex McConnachie, A Gerald Shaper, et al.
BMC Geriatrics|September 19, 2018
Diagnostic test accuracy of a novel smartphone application for the assessment of attention deficits in delirium in older hospitalised patients: a prospective cohort study protocolLisa-Marie Rutter, Eva Nouzova, David J Stott, et al.
Frontiers in Endocrinology|June 7, 2021
Levothyroxine Treatment and Cardiovascular Outcomes in Older People With Subclinical Hypothyroidism: Pooled Individual Results of Two Randomised Controlled TrialsLaurien E Zijlstra, J Wouter Jukema, Rudi G J Westendorp, et al.
Circulation|November 9, 2005
Plasma lipoproteins and apolipoproteins as predictors of cardiovascular risk and treatment benefit in the PROspective Study of Pravastatin in the Elderly at Risk (PROSPER)Chris J Packard, Ian Ford, Michele Robertson, et al.
Pageof 22

Showing results (131-140 of 215) with videos related to

Sort By:
Pageof 22
BMJ (Clinical Research Ed.)|August 1, 2013
Association of visit-to-visit variability in blood pressure with cognitive function in old age: prospective cohort studyBehnam Sabayan, Liselotte W Wijsman, Jessica C Foster-Dingley, et al.
Plos Medicine|June 26, 2009
Are markers of inflammation more strongly associated with risk for fatal than for nonfatal vascular events?Naveed Sattar, Heather M Murray, Paul Welsh, et al.
Journal of Neurology|August 5, 2009
Pravastatin and cognitive function in the elderly. Results of the PROSPER studyStella Trompet, Peter van Vliet, Anton J M de Craen, et al.
The Journal of Clinical Endocrinology and Metabolism|November 9, 2019
Skeletal Effects of Levothyroxine for Subclinical Hypothyroidism in Older Adults: A TRUST Randomized Trial Nested StudyElena Gonzalez Rodriguez, Mirah Stuber, Cinzia Del Giovane, et al.
Current Controlled Trials in Cardiovascular Medicine|July 5, 2002
A Prospective Study of Pravastatin in the Elderly at Risk (PROSPER): Screening Experience and Baseline CharacteristicsIan Ford, Gerard Jan Blauw, Michael B Murphy, et al.
Plos One|June 6, 2012
Genome-wide study of gene variants associated with differential cardiovascular event reduction by pravastatin therapyDov Shiffman, Stella Trompet, Judy Z Louie, et al.
Lancet (London, England)|May 27, 2008
Can metabolic syndrome usefully predict cardiovascular disease and diabetes? Outcome data from two prospective studiesNaveed Sattar, Alex McConnachie, A Gerald Shaper, et al.
BMC Geriatrics|September 19, 2018
Diagnostic test accuracy of a novel smartphone application for the assessment of attention deficits in delirium in older hospitalised patients: a prospective cohort study protocolLisa-Marie Rutter, Eva Nouzova, David J Stott, et al.
Frontiers in Endocrinology|June 7, 2021
Levothyroxine Treatment and Cardiovascular Outcomes in Older People With Subclinical Hypothyroidism: Pooled Individual Results of Two Randomised Controlled TrialsLaurien E Zijlstra, J Wouter Jukema, Rudi G J Westendorp, et al.
Circulation|November 9, 2005
Plasma lipoproteins and apolipoproteins as predictors of cardiovascular risk and treatment benefit in the PROspective Study of Pravastatin in the Elderly at Risk (PROSPER)Chris J Packard, Ian Ford, Michele Robertson, et al.
Pageof 22